Clinical Scorecard: A comprehensive analysis of non-invasive biomarkers for predicting seizures in children with epilepsy
At a Glance
Category
Detail
Condition
Epilepsy with seizures in pediatric patients
Key Mechanisms
Non-invasive physiologic and environmental biomarkers, primarily cardiovascular biomarkers measured by ECG, to forecast seizures before onset
Target Population
Children with epilepsy, including those with refractory epilepsy
Care Setting
Outpatient and clinical settings where seizure forecasting and monitoring can be applied
Key Highlights
Epilepsy affects approximately 50 million people worldwide, with 20–40% experiencing refractory seizures not controlled by medication.
Cardiovascular biomarkers using ECG are the most commonly studied non-invasive predictors, with pre-ictal changes observed from seconds to up to 40 minutes before seizures.
Current evidence quality is low or very low in most studies due to methodological limitations, highlighting the need for larger, more rigorous research.
Guideline-Based Recommendations
Diagnosis
Utilize non-invasive cardiovascular biomarkers such as ECG measurements to identify pre-ictal changes indicative of impending seizures.
Management
Incorporate seizure forecasting algorithms based on non-invasive biomarkers to potentially improve seizure control and reduce unpredictability.
Consider a precision medicine approach tailoring biomarker monitoring and forecasting algorithms to individual patient profiles.
Monitoring & Follow-up
Continuous or periodic monitoring of cardiovascular biomarkers to detect pre-ictal changes within a timeframe ranging from seconds to minutes before seizure onset.
Risks
Recognize that current forecasting methods have low certainty and potential bias; clinical decisions should not rely solely on these biomarkers without further validation.
Patient & Prescribing Data
Pediatric patients with epilepsy, including those with refractory seizures
Seizure forecasting devices based on non-invasive biomarkers are not yet commercially available; however, caregivers express strong interest in such predictive tools to improve quality of life and reduce seizure-related risks.
Clinical Best Practices
Employ non-invasive ECG monitoring as a primary biomarker source for seizure forecasting in children with epilepsy.
Interpret seizure forecasting data cautiously due to current low evidence certainty and methodological limitations in existing studies.
Engage caregivers and patients in discussions about the potential benefits and limitations of seizure prediction technologies.
Support ongoing research efforts to validate and refine non-invasive biomarker algorithms with larger sample sizes and integrated physiologic and environmental data.
Epilepsy remains a life-altering condition, particularly due to the unpredictable nature of seizures and their cumulative impact on cognition, independence and quality of life.
Novo Nordisk’s Parkinson’s cell therapy finds a new home at Cellular Intelligence, while base editing, prime editing, and large-insertion genome writing push forward
